![Pamela Wapnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 248 104 $ al 31/07/2026
Pamela Wapnick is currently Chief Financial Officer at Metagenomi Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at Diality, Inc. from 2022 to 2023, Chief Financial Officer at Capsida Biotherapeutics, Inc. from 2019 to 2022, Chief Financial Officer at Graybug Vision, Inc. from 2017 to 2019, Vice President-Finance at Amgen, Inc. in 2016, and Chief Financial Officer positions at True North Therapeutics, Inc. and Metagenomi Technologies LLC.
Education includes undergraduate studies at Wellesley College and an MBA from Columbia Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2026 | 208.491 ( 0,55 % ) | 248 104 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Director Financiero/CFO | 01/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Director Financiero/CFO | 01/09/2023 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director Financiero/CFO | 01/06/2022 |
| CALCIMEDICA, INC. | Director Financiero/CFO | 01/10/2019 |
| AMGEN INC. | Director Financiero/CFO | 01/03/2016 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
